\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ abdominal\\ distension\ \(0\)\
\-\ diagnosis\\ was\\ established\\ by\\ histopathological\\ examination\\;\\ fna\ \(0\)\
\-\ large\\ heterogeneous\\ mass\\ arising\\ within\\ the\\ pancreatic\\ head\\.\\ body\\ and\\ tail\\ of\\ pancreas\\ unremarkable\\.\ \(0\)\
\-\ non\\-functioning\\ pancreatic\\ islet\\ cell\\ tumor\ \(0\)\
\-\ atypical\\ pancreatic\\ adenocarcinoma\ \(0\)\
\-\ pancreatic\\ islet\\ cell\\ tumor\ \(2\)\
\-\ pancreatic\\ mucinous\\ neoplasm\\ with\\ extensive\ \(0\)\
\-\ \\ \\ \\ \\ solid\\ components\ \(1\)\
\-\ solid\\ and\\ papillary\\ epithelial\\ neoplasm\\ \\(spen\\)\ \(0\)\
\-\ \\ \\ \\ of\\ the\\ pancreas\ \(1\)\
\-\ 42\\ yo\\ pilot\\ with\\ recurrent\\ lymphadenopathy\\;\\ mild\\ luq\\ tenderness\\.\ \(0\)\
\-\ pancreatic\\ islet\\ cell\\ tumor\\ is\\ typically\\ seen\\ as\\ a\\ solid\\ hypervascular\\ pancreatic\\ mass\\,\\ typically\\ located\\ in\\ the\\ pancreatic\\ head\\.\\ \\ these\\ masses\\ may\\ be\\ large\\ at\\ the\\ time\\ of\\ diagnosis\\ \\(over\\ 4cm\\)\\ and\\ have\\ cystic\\ changes\\ and\\ necrosis\\.\ \(0\)\
\-\ islet\\ cell\\ tumor\\ subtypes\\ include\\ insulinoma\\ \\(most\\ common\\ type\\)\\,\\ gastrinoma\\ \\(associated\\ with\\ zollinger\\-ellison\\ syndrome\\)\\,\\ and\\ non\\-functioning\\.\ \(0\)\
\-\ islet\\ cell\\ tumors\\ are\\ typically\\ sporadic\\ but\\ can\\ be\\ seen\\ in\\ multiple\\ endocrine\\ neoplasia\\ \\(men\\)\\ syndromes\\,\\ men\\ 1\\ in\\ particular\\,\\ and\\ von\\ hippel\\ lindau\\ syndrome\\.\\ \\ \ \(0\)\
\-\ malignant\\ transformation\\ occurs\\ in\\ up\\ to\\ 80\\%\\ of\\ patients\\ with\\ non\\-functioning\\ islet\\ cell\\ tumor\\.\\ \\ nodular\\ calcifications\\ are\\ seen\\ in\\ 20\\-25\\%\\,\\ with\\ contrast\\ enhancement\\ on\\ ct\\ in\\ 83\\%\\ of\\ non\\-functioning\\ islet\\ cell\\ tumor\\ cases\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ islet\\:\\ 0\\.2140357804973202\ \(0\)\
\-\ pancreatic\\:\\ 0\\.16557581923710346\ \(0\)\
\-\ non\\-functioning\\:\\ 0\\.14269466359470095\ \(0\)\
\-\ cell\\:\\ 0\\.07998853951024953\ \(0\)\
\-\ tumor\\:\\ 0\\.05917521687952904\ \(0\)\
\-\ solid\\:\\ 0\\.050619009690688804\ \(0\)\
\-\ men\\:\\ 0\\.047787469083190336\ \(0\)\
\-\ typically\\:\\ 0\\.044798402517415424\ \(0\)\
\-\ pancreas\\:\\ 0\\.04329571452946714\ \(0\)\
\-\ spen\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ hippel\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ lindau\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ histopathological\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ pilot\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ insulinoma\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ zollinger\\-ellison\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ gastrinoma\\:\\ 0\\.034771083934348725\ \(0\)\
\-\ 20\\-25\\:\\ 0\\.032242244212734916\ \(0\)\
\-\ luq\\:\\ 0\\.03057654007104574\ \(0\)\
\-\ \\%\\:\\ 0\\.02960377772296051\ \(0\)\
\-\ neoplasia\\:\\ 0\\.02933240923797195\ \(0\)\
\-\ neoplasm\\:\\ 0\\.028813431444672556\ \(0\)\
\-\ fna\\:\\ 0\\.02856928706060928\ \(0\)\
\-\ subtypes\\:\\ 0\\.02856928706060928\ \(0\)\
\-\ 4cm\\:\\ 0\\.02732515622753549\ \(0\)\
\-\ sporadic\\:\\ 0\\.02732515622753549\ \(0\)\
\-\ von\\:\\ 0\\.026641243660798772\ \(0\)\
\-\ endocrine\\:\\ 0\\.026183949996783844\ \(0\)\
\-\ established\\:\\ 0\\.025900987552031626\ \(0\)\
\-\ epithelial\\:\\ 0\\.025765349065951848\ \(0\)\
\-\ 83\\:\\ 0\\.025765349065951848\ \(0\)\
\-\ mucinous\\:\\ 0\\.025379400840854265\ \(0\)\
\-\ seen\\:\\ 0\\.025078627946549855\ \(0\)\
\-\ hypervascular\\:\\ 0\\.025021377763727405\ \(0\)\
\-\ distension\\:\\ 0\\.024581043674536833\ \(0\)\
\-\ syndrome\\:\\ 0\\.024197094819154868\ \(0\)\
\-\ syndromes\\:\\ 0\\.024176696986347387\ \(0\)\
\-\ head\\:\\ 0\\.023996052579939565\ \(0\)\
\-\ transformation\\:\\ 0\\.02398626985353652\ \(0\)\
\-\ tail\\:\\ 0\\.02329031960293657\ \(0\)\
\-\ particular\\:\\ 0\\.02268025702658039\ \(0\)\
\-\ mild\\:\\ 0\\.02227973716763502\ \(0\)\
\-\ papillary\\:\\ 0\\.021476146581625204\ \(0\)\
\-\ 42\\:\\ 0\\.021420208189279005\ \(0\)\
\-\ components\\:\\ 0\\.020745275300407064\ \(0\)\
\-\ \\;\\:\\ 0\\.020053675133193997\ \(0\)\
\-\ 80\\:\\ 0\\.01989964296222652\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01942791416614277\ \(0\)\
\-\ large\\:\\ 0\\.018500420117139402\ \(0\)\
\-\ atypical\\:\\ 0\\.018334310077277007\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.018275022002788313\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.01798878650333868\ \(0\)\
\-\ \\(\\:\\ 0\\.01788024074861041\ \(0\)\
\-\ recurrent\\:\\ 0\\.01785164490655979\ \(0\)\
\-\ nodular\\:\\ 0\\.01774460300550451\ \(0\)\
\-\ \\)\\:\\ 0\\.017661824062210525\ \(0\)\
\-\ arising\\:\\ 0\\.01751189982542565\ \(0\)\
\-\ located\\:\\ 0\\.017411886422863673\ \(0\)\
\-\ occurs\\:\\ 0\\.017362627359234124\ \(0\)\
\-\ extensive\\:\\ 0\\.016917602586379928\ \(0\)\
\-\ necrosis\\:\\ 0\\.016698518383389628\ \(0\)\
\-\ tumors\\:\\ 0\\.015889684938962877\ \(0\)\
\-\ calcifications\\:\\ 0\\.015728533438776\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.015555421568292106\ \(0\)\
\-\ malignant\\:\\ 0\\.015290448892966838\ \(0\)\
\-\ masses\\:\\ 0\\.014299962366317264\ \(0\)\
\-\ type\\:\\ 0\\.014260515981915398\ \(0\)\
\-\ cases\\:\\ 0\\.014093123089015508\ \(0\)\
\-\ unremarkable\\:\\ 0\\.01400527930040624\ \(0\)\
\-\ body\\:\\ 0\\.013738929270738042\ \(0\)\
\-\ examination\\:\\ 0\\.01315060908650775\ \(0\)\
\-\ be\\:\\ 0\\.013047096270731971\ \(0\)\
\-\ tenderness\\:\\ 0\\.012865902588522937\ \(0\)\
\-\ yo\\:\\ 0\\.012729462986647337\ \(0\)\
\-\ in\\:\\ 0\\.012516749410106581\ \(0\)\
\-\ cystic\\:\\ 0\\.012201152016097814\ \(0\)\
\-\ changes\\:\\ 0\\.012123999882351785\ \(0\)\
\-\ time\\:\\ 0\\.01194852092692729\ \(0\)\
\-\ include\\:\\ 0\\.01186709647539746\ \(0\)\
\-\ mass\\:\\ 0\\.011766940662847173\ \(0\)\
\-\ are\\:\\ 0\\.011533404678510908\ \(0\)\
\-\ up\\:\\ 0\\.011375480945812987\ \(0\)\
\-\ enhancement\\:\\ 0\\.011339053297638792\ \(0\)\
\-\ common\\:\\ 0\\.011070629762160382\ \(0\)\
\-\ these\\:\\ 0\\.01100913213840515\ \(0\)\
\-\ patients\\:\\ 0\\.010948389105772406\ \(0\)\
\-\ over\\:\\ 0\\.010770507871980013\ \(0\)\
\-\ abdominal\\:\\ 0\\.010573857614465916\ \(0\)\
\-\ 1\\:\\ 0\\.010065972118612411\ \(0\)\
\-\ associated\\:\\ 0\\.009982487930236148\ \(0\)\
\-\ most\\:\\ 0\\.009766510602614239\ \(0\)\
\-\ can\\:\\ 0\\.009595160160737968\ \(0\)\
\-\ contrast\\:\\ 0\\.009469186568355967\ \(0\)\
\-\ may\\:\\ 0\\.009278853311376851\ \(0\)\
\-\ have\\:\\ 0\\.00916058454636184\ \(0\)\
\-\ but\\:\\ 0\\.009022293569472959\ \(0\)\
\-\ multiple\\:\\ 0\\.00890993071029341\ \(0\)\
\-\ within\\:\\ 0\\.00806995746725783\ \(0\)\
\-\ \\,\\:\\ 0\\.008040893035166951\ \(0\)\
\-\ by\\:\\ 0\\.00704391536259839\ \(0\)\
\-\ as\\:\\ 0\\.006398898544030336\ \(0\)\
\-\ ct\\:\\ 0\\.00591734481877249\ \(0\)\
\-\ at\\:\\ 0\\.0057315007565922425\ \(0\)\
\-\ and\\:\\ 0\\.005346802150461934\ \(0\)\
\-\ was\\:\\ 0\\.004892462981255875\ \(0\)\
\-\ on\\:\\ 0\\.0035836188730961785\ \(0\)\
\-\ with\\:\\ 0\\.0028961429725220234\ \(0\)\
\-\ of\\:\\ 0\\.0028837574454947633\ \(0\)\
\-\ is\\:\\ 0\\.0027836177147758695\ \(0\)\
\-\ the\\:\\ 0\\.0027376095980916\ \(0\)\
\-\ to\\:\\ 0\\.002114198556648447\ \(0\)\
\-\ a\\:\\ 0\\.00196336535553763\ \(0\)\
\-\ \\.\\:\\ 0\\.001581662499386715\ \(0\)\
